In order to study the function of the Mycobacterium tuberculosis protein ESAT-6 in the infection process, we searched for host proteins that interact with this secreted mycobacterial protein.
Introduction
Mycobacterium tuberculosis is a pathogen that persists intracellularly in host macrophages and can cause chronic disease in susceptible individuals. The prevention of phagosome maturation and activity represents a major survival strategy of M. tuberculosis [1] . Experiments using in vitro infection of macrophages have demonstrated a profound inhibitory influence of M. tuberculosis cells on their cellular host. Upon infection, M. tuberculosis modifies the gene expression of the host macrophage, which results in a highly sophisticated interaction between the pathogen and its host. One example is the ability of M. tuberculosis to alter macrophage intracellular signalling required for the production of immunostimulatory cytokines and effector molecules [2] [3] [4] . Furthermore, microarray studies have shown M. tuberculosis-specific inhibition of interleukin-12 expression, a cytokine critical for control of mycobacterial infection [5] . Another important feature of mycobacterial subversion of host immune function is the induction of macrophage unresponsiveness to interferon-γ [6, 7] , a T-cell cytokine crucial for optimal macrophage activation and subsequent synthesis of bactericidal molecules such as oxygen and nitrogen radicals [8, 9] .
Proteins secreted by M. tuberculosis into the culture medium represent candidates for mycobacterial down-regulation of macrophage function. This concept is based on the findings that live, but not dead, M. tuberculosis cells prevent phagosomal-lysosomal fusion and expression of co-stimulatory molecule B7 in infected macrophages [10, 11] . The secreted proteins of M. tuberculosis and M. bovis, ESAT-6 and CFP-10, are particularly interesting because these proteins represent potent T-cell antigens [12] [13] [14] , and recent studies suggested a role in virulence [15] . ESAT-6 and CFP-10 form a heterodimeric complex [16] [17] [18] that is exported by an alternative Sec-independent secretion system [18] [19] [20] . The corresponding genes esxA and esxB are co-ordinately expressed as an operon [13] and are located within the chromosomal RD1 region (region of difference), which is deleted in all of the attenuated M. bovis BCG and M. microti live vaccine strains [21] . Deletion of the entire RD1 region from M. tuberculosis, and the deletion of the esxA gene from a virulent M. bovis strain, results in a marked reduction in virulence [18, 19, [22] [23] [24] . Conversely, integration of the RD1 region from M. tuberculosis into M. bovis BCG and M. microti restored ESAT-6 and CFP-10 expression, and increased virulence and immunogenicity [21, 25, 26] . Using transparent zebrafish embryos to monitor the infection process by M. marinum in real time, Volkman et al. [27] found that RD1-deficient bacteria fail to elicit efficient granuloma formation. It was shown that macrophages infected with virulent mycobacteria produce an RD-1 dependent signal that directs macrophages to aggregate into granulomas. This Mycobacterium-induced macrophage aggregation in turn is tightly linked to intercellular bacterial dissemination and increased bacterial numbers.
To obtain a more detailed insight into the pathogen-host relationship, a yeast twohybrid system was employed in the present study to identify host proteins which bind to ESAT-6 of M. tuberculosis.
Material and methods

Reagents, strains and media
Yeast nitrogen base was purchased from Q-BIOgene, 3-aminotriazole (3-AT) from Sigma, restriction enzymes from Roche Diagnostics or Pharmacia, ProofStart DNA polymerase from Qiagen and complete protease inhibitor cocktail (EDTA-free) from Roche Diagnostics. Antibodies were purchased from DakoCytomation (Glostrup, Denmark) (anti-rabbit HRP antibody conjugate (P0217), anti-mouse HRP antibody conjugate (P0260) and antigoat HRP antibody conjugate (P0160)), from Sigma (rabbit anti-GST IgG (G7781) and anti-polyHistidine antibody (H1029)). The anti-syntenin antibody used in peptide spot analysis was purchased from Santa Cruz Biotechnology (anti-syntenin(G15) goat IgG (sc-19380)) and the anti-syntenin antibody used to detect co-purification of macrophage derived syntenin was from Synaptic Systems, Germany. The monoclonal antibody against ESAT-6 (HYB 76-8) has been described previously [12] . The anti-penta-His antibody was purchased from Qiagen (Germany). M. tuberculosis H37Rv genomic DNA was kindly provided by Roland Brosch (Institut Pasteur, Paris). Bacterial and yeast strains used are listed in Table 1 . Escherichia coli strains were grown in Luria-Bertani (LB) broth or on LB agar plates at 37
• C . LB was supplemented with ampicillin (100 μg ml −1 ) or kanamycin (50 μg ml −1 ). Saccharomyces cerevisiae strains were grown at 30
• C in SC drop-out, YPD liquid media or on agar plates. The RD1-2F9 and 2F9-EsxA-HIS constructs have been previously described [21, 28] . BCG::2F9-EsxA-HIS and BCG::RD1-2F9 cultures were grown in Sauton's media (Difco Laboratories, USA) supplemented with hygromycin (50 μg ml −1 ).
Plasmid construction
To generate bait plasmids, the DNA sequence encoding full-length ESAT-6 (Rv3875) was PCR amplified from M. tuberculosis H37Rv genomic DNA and cloned into pTM152 to generate pGH34. The C-terminal half of ESAT-6 (amino acids 49 to 95) was cloned into pTM152 after amplification of nucleotides 145 to 288 to generate pGH5. The N-terminal half of ESAT-6 (amino acids 1 to 48) was cloned into pGBT9 after amplification of nucleotides 1 to 144 to generate pGH3. M. tuberculosis genes encoding ESXT (Rv3444c) and ESXS (Rv3020c) were PCR amplified and inserted into GAL4-BD vectors to generate pGH25 and pGH43. CFP-10 (Rv3874) was cloned as a Gal4-AD fusion into pACT2 to give pGH37. Rattus norvegicus cDNA encoding syntenin-1 (CAC21602) was PCR amplified from a rat lung MATCHMAKER cDNA library (Clontech) and cloned using the EcoRI and XhoI sites of pACT2 to generate psyn1. psyn1 was used as a template to amplify fragments encoding parts of syntenin-1 which were cloned as in-frame Gal4-AD fusions into pACT2 to generate psyn2 to psyn7.
Human cDNA encoding syntenin-1 (AAB97144) was PCR amplified from a human brain MATCHMAKER cDNA library (Clontech) and cloned into pENTR/D-TOPO (Invitrogen) according to the manufacturer's protocol. The cloned gene was transferred to pDEST17 by LR recombination according to the Gateway protocol (Invitrogen). Using the same method, the gene encoding ESAT-6 was cloned into pENTR/D-TOPO and then transferred into pDEST17. All constructs were verified by sequencing. See Table 1 for details. The primer sequences used are available upon request.
Yeast-two-hybrid assay
S. cerevisiae MaV203 was transformed with the appropriate combinations of plasmids by a LiAc transformation procedure according to the MATCHMAKER protocols (Clontech). Screening for interaction of fusion proteins was performed by plating transformants onto plates lacking leucine, tryptophan, histidine and uracil. Alternatively, MaV203 was transformed with a cDNA prey library and the resulting cells were mated with Y190 cells transformed with the bait constructs. Resulting diploid cells were selected for interaction by plating on leucine-, tryptophan-and histidine-deficient media containing 10 -40 μM 3-AT. Selected transformants were tested for β-galactosidase expression either by a filter lift assay with 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) as a substrate, or by an in vivo plate assay using X-gal in the media according to the MATCHMAKER protocols. β-galactosidase activity was quantified by a o-nitrophenyl-β-D-galactopyranoside (ONPG) liquid culture assay [29] . Hydrolysis of ONPG was measured photometrically at 420 nm upon permeabilization of cells. Enzymatic activity was normalized to cell culture density and expressed as arbitrary units.
To rescue plasmids from positive yeast clones, plasmid DNA was extracted according to Clontech's yeast protocols handbook and used to transform electrocompetent E. coli KC8 cells. This strain allows the differentiation between clones transformed with bait or prey constructs by nutritional selection.
Expression of recombinant proteins
The expression and purification of His-tagged recombinant M. tuberculosis proteins ESAT-6, CFP-10 and TB10.4 (Rv0288) has been described previously [14, 30, 31] . The protein concentrations of purified recombinant proteins were determined using a bicinchoninic assay (Pierce, Rockford, IL, USA) according to the manufacturer's instructions.
His-tagged ESAT-6 and human syntenin-1 used in surface plasmon resonance and peptide spot studies were expressed from Gateway pDEST17 vectors in E.coli BL21AI. E.coli cells expressing His-tagged proteins were sonicated in lysis buffer containing 50 mM Tris/HCl pH 8, 100 mM NaCl, 5 % glucose, 0.25 % Igepal (CA-630/Sigma), 3 mM 2-mercaptoethanol, 1.5 M urea. A protease inhibitor cocktail was added to the lysis buffer. After sonification, 1 % Triton X-100 was added and the suspension agitated for 30 min at 4
• C. Proteins were purified from the clarified cell lysate using TALON metal affinity resins (Clontech) according to the manufacturer's instructions. Table 1 Plasmids and strains used in this study.
Ligand overlay
This was performed as previously described [31] . Briefly, samples of recombinant proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes by semidry electroblotting. The membrane was blocked over night in PBS buffer with 0.1 % Tween 20 (PBS-T) and 5 % skimmed milk powder. Thereafter, the membrane was incubated with 10 μg/ml of recombinant ESAT-6 in PBS-T with 1 % skimmed milk powder over night, followed by incubation with the anti-ESAT-6 specific antibody (HYB 76-8) in PBS-T with 1 % skimmed milk powder. Binding of recombinant ESAT-6 to samples applied on SDS-PAGE was detected using alkaline phosphatase-conjugated rabbit-anti-mouse antibodies D314 from DakoCytomation (Glostrup, Denmark).
Peptide spot analysis
ESAT-6 peptide fragments were synthesised as overlapping linear 13mer peptides with a 10mer overlap, and were covalently bound by the C-terminus to Whatman 50 cellulose support (Jerini Peptide Technologies). The membrane was rinsed for 1 min in ethanol, blocked over night in 5 % albumin (Sigma) in TBE-buffer (50 mM Tris/HCl, 137 mM NaCl, 2.7 mM KCl, pH 8.0) and washed three times with buffer TTBE-buffer (TBEbuffer with 0.05 % Tween). The membrane was incubated with 1 μg of His-tagged human syntenin-1 in 2 ml TTBE for 3 hours at 4
• C, washed three times with TTBE and incubated further with anti-syntenin antibodies for 3 hours at room temperature. After further washing the membrane was incubated over night with a HRP-coupled secondary antibody at 4 • C, followed by thorough washing and visualized using ECL T M (Amersham Biosciences) and exposure to X-ray film (Kodax, Amersham Pharmacia Biotech).
Surface plasmon resonance binding assay
Direct interaction of ESAT-6 and syntenin-1 was monitored using a BIACORE 3000 biosensor (Biacore AB, Uppsala, Sweden). Recombinant His-tagged ESAT-6 (dialysed against 10 mM acetate buffer, pH 3.5) was coupled to the flow cells of a sensor chip (carboxymethylated dextran chip CM5, Biacore AB) using 100 mM N-hydroxysuccinimide and 400 mM N-ethyl-N'-(dimethylaminopropyl) carbodiimide until an appropriate level of coupling (3500 resonance units) was reached. Deactivation after immobilization was achieved using 1 M ethanolamine (pH 8.5). All binding studies were performed in 75 mM phosphate buffered saline, pH 7.5 using a flow rate of 5 μl min −1 at 25 • C . A control flow cell was prepared under identical conditions in the absence of protein using acetate buffer. Recombinant His-tagged syntenin-1 was dialysed against running buffer and injected in different concentrations into the flow cell coupled with ESAT-6.
Protein extraction, column purification and immunoblotting
Culture filtrates were prepared from early log phase cultures of BCG::2F9-EsxA-HIS and BCG::RD1-2F9 grown in Sauton's media, and were concentrated using Centricon filter devices with a 3 kDa cutoff (Millipore, Bedford, MA, U.S.A.). The mouse macrophage cell-line RAW 264.7 was cultured in Dulbecco's modified Eagle's medium (D-MEM) and supplemented with 10 % fetal calf serum (FCS) (Gibco, Paisley, Scotland UK). The cells were grown in 75 cm 2 tissue culture flasks to near-confluency, washed and scraped into cold PBS. Subsequently the cells were collected by centrifugation and resuspended in homogenization buffer (10 mM Tris-HCl, pH 7.3, 200 mM sucrose) supplemented with EDTAfree protease inhibitor (Roche, Mannheim, Germany). To obtain crude macrophage cell lysates the cells were lysed by a freeze-thaw method followed by centrifugation at 300 x g for 10 min to remove unbroken cells.
C-terminal His-tagged ESAT-6 was purified using mini-columns containing 80 μl Ni 2+ nitrilotriacetic acid (NTA) agarose (Qiagen, Germany). Culture filtrates (20 μg total protein) were passed through the mini-columns and washed with phosphate buffered saline (PBS), (pH 7.3) with 300 mM NaCl and 20 mM Imidazole (buffer A). Crude macrophage cell lysates (≈ 1 mg) were passed through the columns and washed extensively with buffer A. Bound protein was eluted with PBS containing 300 mM NaCl and 250 mM Imidazole. Samples were precipitated with 10 % TCA, dissolved in PBS and separated by SDS-PAGE before blotting onto a nitrocellulose membrane. Western blotting was performed as described previously [21] using anti-ESAT-6 (HYB 76-8) monoclonal antibodies to control His-tag mediated ESAT-6 binding (data not shown). Syntenin was detected by polyclonal anti-syntenin antibody (Synaptic Systems, Germany) (diluted 1:500) and horse radish peroxidase labelled anti-rabbit antibody (Amersham Biosciences, UK) (diluted 1:5000).
Results
Yeast two-hybrid screens identified syntenin-1 as an ESAT-6 interacting protein
A yeast two-hybrid approach was used to identify host proteins that interact with ESAT-6. For this purpose, the complete ESAT-6 gene was cloned into a two-hybrid bait expression vector. The resulting Gal4-ESAT-6 fusion protein was used to screen a rat lung cDNA library. The selection criteria for positive interactions were expression of the reporter genes HIS 3, URA3 and lacZ. Amongst 3.4 x 10 6 transformants two interacting clones were isolated. Sequence analysis revealed that the inserts of these two clones match with the cDNA encoding rat syntenin-1, but differed in the length of the 5' untranslated region within the prey constructs. To exclude any influence of this region on the interaction with ESAT-6, the entire coding sequence of syntenin-1 was amplified by PCR using the two hybrid cDNA library as template and cloned into the two-hybrid vector pACT2 to generate psyn1. Thus, psyn1 encodes a protein composed of the entire syntenin-1 coding region, but lacking any additional amino acids fused to the Gal4-AD.
Syntenin-1 interaction with ESAT-6 was assayed in the yeast strain MaV203 cotransformed with pGH34 and psyn1 (Table 1) . Double transformants were plated on medium lacking tryptophan, leucine, histidine and uracil, or on medium deficient in tryptophan and leucine supplemented with X-gal. Growth on histidine and uracil deficient medium and the blue colour on X-gal medium demonstrates interaction of ESAT-6 and syntenin-1, which results in reporter gene induction in the yeast strain.
To exclude false positive interactions due to transcriptional activation of Gal4-BD-ESAT-6 or artificial DNA binding activity of Gal4-AD-syntenin-1 the plasmids were cotransformed with corresponding two-hybrid plasmids lacking inserts. Under these conditions no lacZ or URA3 reporter gene expression was observed (Fig. 1) .
The specificity of the ESAT-6/syntenin-1 interaction was verified by testing the interaction of syntenin-1 with ESXS (Rv3020c) and ESXT (Rv3444c), two other members of the mycobacterial ESAT-6 protein family. No interaction of syntenin-1 with the ESXS and ESXT proteins was observed in the yeast two-hybrid assay, thus demonstrating specificity for syntenin-1 interaction with ESAT-6 (Fig. 1) .
To assay the stringency of the ESAT-6/syntenin-1 interaction, the expression of the lacZ reporter was quantified. As shown in Figure 1 , the activity in cells expressing Gal4-BD-ESAT-6 and GAL4-AD-syntenin-1 was about 80 times higher when compared to strains expressing one of the two fusion proteins alone.
As ESAT-6 is secreted as a tight functional complex with its genome partner CFP-10 a yeast three hybrid approach was used to test whether heterodimerisation of ESAT-6 with CFP-10 influences the interaction of ESAT-6 with syntenin-1 (data not shown). LacZ expression levels were comparable in cells co-transformed with pGH34 and psyn1 (BD-ESAT-6 + AD-syntenin) and in cells co-transformed with BD-ESAT-6 + NLS-CFP-10 + AD-syntenin.
Confirmation of ESAT-6/syntenin-1 interaction by in vitro methods
ESAT-6 and human syntenin-1 were expressed recombinantly in E. coli as His-tagged proteins and used to confirm the interaction by biochemical means. The molecular weight of His-ESAT-6 is 12.5 kDa and of His-syntenin-1 35 kDa. The interaction between the proteins was confirmed by several in vitro binding assays using the purified proteins.
Ligand overlay. Purified recombinant proteins were separated by SDS-PAGE, transferred to a membrane and assayed by Western blotting. The bands observed after Coomassie staining ( Fig. 2A) were additionally detected after incubation with anti-His antibodies (data not shown). The anti-ESAT-6 antibody reacted specifically with the 12.5 kDa ESAT-6 protein (Fig. 2B, lane 3) . The epitope recognized by the monoclonal ESAT-6 antibody is located at the N-terminus of ESAT-6 [30] . The Coomassie staining of ESAT-6 showed one major band, however the Western blot showed several larger and smaller bands. It is probable that these additional bands most likely represent dimeric and processed forms of ESAT-6. Following incubation with ESAT-6, the membrane was developed with anti-ESAT-6 antibodies and showed that the antibody identified the ESAT-6 protein (Fig. 2C, lane 3) ; but also the ESAT-6 bound to syntenin-1 (lane 4) and CFP-10 (lane 2) which was used as a positive control. ESAT-6 did not bind to the ESAT-6 like protein TB10.4 (CFP-7, EsxH) which was used as a negative control (lane 1). The binding of recombinant ESAT-6 to CFP-10, but not to TB10.4, is in agreement with previously published results [16, 31] .
The binding of recombinant ESAT-6 to syntenin-1 confirmed the results obtained with the yeast two-hybrid system. Fig. 1 Quantitative assay of β-galactosidase activity. The MaV203 strain was transformed with plasmids encoding the proteins indicated as fusion to Gal4-BD (ESAT-6, ESXT, ESXS) or to Gal4-AD (syntenin-1, CFP-10). Double transformants with ESAT-6 and syntenin-1, and the corresponding two-hybrid vectors lacking ESAT-6 and syntenin-1 sequences, excluded false positive interactions. Double transformants expressing Gal4-AD-syntenin fusions together with Gal4-BD-ESXS and Gal4-BD-ESXT fusions, respectively, demonstrate the specificity of ESAT-6/syntenin-1 interaction. As a reference we used the interaction of ESAT-6/CFP-10, and control strain D from the ProQuest twohybrid system (GibcoBRL) which is transformed with strong interacting constructs containing cDNAs encoding rat cFos and mouse cJun (5) . Each bar represents the mean β-galactosidase activity from three independent transformants, each measured in triplicate.
Surface plasmon resonance. The binding of syntenin-1 to ESAT-6 was confirmed using a surface plasmon resonance technique. Recombinant ESAT-6 protein was immobilised on a CM5 Biosensor chip and syntenin-1 was injected into the fluid phase. Syntenin-1 bound dose-dependently to ESAT-6 and this binding was specific as no interaction occurred to the control cell (Fig. 3) . Co-purification of secreted ESAT-6 and macrophage derived syntenin. In order to further examine the specific interaction between native ESAT-6 and syntenin-1, proteins were isolated from culture filtrates and whole macrophage lysates, respectively. Culture filtrates from a M. bovis BCG mutant expressing and secreting his-tagged ESAT-6 were concentrated and column purified. Highly efficient Ni 2+ -NTA affinity purification of C-terminal His-tagged ESAT-6 was previously demonstrated [28] but could not be repeated with N-terminal His-tagged ESAT-6, probably due to cleavage of the tag. Immobilized C-terminal His-tagged ESAT-6 was tested for interaction with syntenin-1 present in crude macrophage lysates. Only ESAT-6 mediated this interaction and no unspecific binding of syntenin-1 to the column was detected (Fig. 4A) . The eluates of columns preincubated with culture filtrates containing ESAT-6 with and without C-terminal his-tags were analyzed by SDS-PAGE and Western blotting. Despite background signal (lane 3) a clear difference was observed in syntenin-1 specific interaction (Fig. 4B) , showing that this protein could be co-purified with ESAT-6-his. Fig. 3 Binding of syntenin-1 to ESAT-6 determined by surface plasmon resonance. 6X His-tagged ESAT-6 was immobilized onto a CM5 Biosensor chip. 6X His-tagged syntenin-1 was injected at concentrations of 50, 37.5, and 25 μg/ml, respectively.
Fig. 4 Co-purification of ESAT-6 and syntenin-1 as determined by Ni
2+ -NTA binding of His-tagged ESAT-6, purified from recombinant BCG culture filtrates, and macrophage derived syntenin-1. By Western blotting analysis, using anti-syntenin-1 antibody (A and B), specific co-purification was detected using columns with (+) and without (-) pre-incubation of culture filtrate containing his-tagged ESAT-6 (A). To confirm the specificity, columns were incubated with culture filtrates containing ESAT-6 with or without His-tag, and subsequently incubated with similar amounts of crude macrophage lysates (lane 2 and 4). Eluates were collected, precipitated and loaded on SDS-PAGE gel (laneDomains of syntenin-1 and ESAT-6 involved in interaction. In order to localize interaction domains of syntenin-1 and ESAT-6, deletion fragments of syntenin-1 were generated and expressed as Gal4-AD fusion proteins. The various deletion constructs were tested in two-hybrid assays in combination with plasmids that encode the entire ESAT-6 protein, the N-terminal or the C-terminal part of the protein as Gal4-BD fusion at the N-terminus.
The reporter gene activity, shown in Fig. 5 , demonstrates that both PDZ-domains of syntenin-1 are essential for binding the C-terminal part of ESAT-6 with the strongest interaction detected when both proteins were complete. The N-terminal regions of both proteins did not bind to the complete partner proteins, but they do contribute to the interaction of the complete proteins. Table 1 ) were used in yeast two-hybrid assays in combination with pGH34, pGH3 or pGH5, encoding entire ESAT-6, the N-terminal or the C-terminal part thereof as Gal4-BD fusion, respectively. The β-galactosidase activity was normalized to that of the interaction between entire syntenin-1 and entire ESAT-6 which is set to 100 %.
Binding of syntenin-1 to linear peptides of ESAT-6. Peptide fragments representing the entire ESAT-6 protein were synthesised as overlapping linear 13 mer peptides with a 10 mer overlap, and were covalently bound by the C-terminus to a membrane. After incubation with recombinant syntenin-1, bound syntenin-1 was detected by Western blotting (see Fig. 6 ). The assay localized a linear binding domain in the N-terminal region and two weaker binding domains in the central and the C-terminal region of ESAT-6. 
Discussion
In order to identify host proteins interacting with the secreted M. tuberculosis protein ESAT-6, a yeast two-hybrid system was used to screen a rat lung cDNA library. Syntenin-1 was identified as an ESAT-6 interacting protein. Both proteins were expressed in E. coli and recombinant proteins were used in biochemical assays to confirm the binding in vitro by ligand overlay, surface plasmon resonance, and peptide spot analysis. Copurification analysis confirmed the interaction between mycobacterial expressed ESAT-6 and macrophage derived syntenin-1.
Quantitative β-galactosidase assays using truncated syntenin-1 and ESAT-6 deletion fragments identified both PDZ-domains of syntenin-1 as essential binding domains. ESAT-6 binds to the PDZ-domains by its C-terminus which is highly suggestive of a classical PDZ interaction. Although differences in expression levels and/or in nuclear targeting of the fusion protein constructs cannot be excluded, the results indicate a contribution of the N-terminal parts of both complete proteins to a stronger interaction. However, interaction between the isolated N-terminal part of ESAT-6 and the complete syntenin-1 is hindered due to steric blocking of the N-terminal fusions in the yeast two-hybrid assay. In the complementary peptide spot analysis untagged N-terminal fragments were able to interact in vitro. A binding domain in the ESAT-6 N-terminus was identified. In contrast, binding of the last C-terminal amino acids of ESAT-6 to the PDZ-domains of syntenin-1 was not detectable by the peptide spot analysis as the peptides are bound to the cellulose support by their C-terminus. The results of the two methods in combination suggest that in vivo the binding of the C-terminus of ESAT-6 to both PDZ domains of syntenin-1 is indispensable for interaction and additional interactions between the domains located towards the N-terminus stabilize the complex.
Although this has already been described for other PDZ domains and their target proteins [32, 33] this is the first example of a protein that binds to syntenin-1 at more than one domain. The other known proteins that interact with syntenin-1 bind either to PDZ domains, e.g. syndecan [34] , proTGF-aplha [35] , schwannomin [36] , rat protein tyrosine phosphatase η [37] , neurofascin [38] , merlin [39] , and IL-5Rα [40] , or to domains outside of the PDZ domains like transcription factor Sox4 [40] . This unique binding characteristic might be of functional significance preventing syntenin-1 from acting as an adaptor/scaffold protein, and from its coordinating function in cell signalling. In preliminary studies (data not shown) heterologous expression of ESAT-6 in a syntenin-1 overexpressing human breast cancer cell line was followed by dramatic morphological changes of the cells including loss of their ability to adhere. Additionally, expression of syntenin-1 became diminished in such cells. The correlation of a 12.5-fold down-regulation of syntenin-1 in macrophages, the only prominent alteration in early gene expression after infection by M. tuberculosis [41] , is intriguing.
Recently, Renshaw et al. [17] determined the structure for the tight 1:1 complex formed by CFP-10 and ESAT-6. In accordance with our results demonstrating an ESAT-6/syntenin-1 interaction, Renshaw et al. [17] clearly indicate that the ESAT-6 backbone in the complex is accessible for interaction with other proteins. Their data demonstrates free access to the ESAT-6 interaction domains we have identified here for syntenin-1.
As we could demonstrate by a yeast three hybrid approach, interaction in yeast was not influenced by co-expression of ESAT-6 and CFP-10.
The specificity of interaction between ESAT-6 and syntenin-1 was demonstrated by the yeast two-hybrid system using ESXS and ESXT, additional M. tuberculosis proteins of the ESAT-6 family. Neither protein interacted with syntenin-1.
Syntenin-1 (also known as syndecan binding protein, melanoma differentiation-associated protein 9 or TGF-alpha cytoplasmic domain-interacting protein 18) obviously plays a role at the cross-sections of pathways that control vesicular trafficking, cytoskeletal dynamics, protein turnover, cell adhesion and in signalling pathways involved in cell differentiation. It was originally identified as a protein that binds to the cytoplasmic domains of syndecans, demonstrated by yeast two-hybrid screens and by in vitro assays [41] . Syntenin-1 contains a tandem repeat of PDZ domains that interacts with the FYA C-terminal amino acids of the syndecan. In this way, syntenin-1 may function as an adaptor that couples syndecans to cytoskeletal proteins or cytosolic downstream signal effectors [42, 43] . Syndecans are ubiquitous transmembrane proteoglycans that bind to a range of ligands outside the cell such as growth factors and matrix proteins. Thus they control a wide variety of cellular processes like cell adhesion, cytoskeletal organization, cell proliferation and migration in response to growth factors [44] [45] [46] [47] . Syntenin-1 is a member of the family of PDZ proteins believed to act as scaffold proteins. These proteins normally possess more than one binding partner. It has been demonstrated that the functional properties of human syntenin-1 are a result of independent interaction of the PDZ domains with target proteins. The independent binding of merlin by PDZ1 and syndecan-4 by PDZ2 provides direct evidence for the coupling of syndecan-mediated signaling to actin regulation by merlin [48] . These examples highlight the involvement of syntenin-1 in regulation of intracellular trafficking processes, and suggests that alteration or downregulation of the physiological functions of syntenin-1 by binding of ESAT-6 might modify the normal phagosomal trafficking pathway.
Syntenin-1 was also identified as an interaction partner of the transmembrane protein tyrosine phosphatase CD148 [49] . Several groups observed a negative regulation of T cell activation by CD148, suggesting that it might play a role in feedback inhibition of the T cell immune response [50, 51] . Both CD4+ and CD8+ T cells participate in the immune response to tuberculosis, and similar T cell mechanisms contribute to protection as well as to pathogenesis. Protection against tuberculosis, therefore, depends on subtle coordination of the immune response [52] . Syntenin-1 was also reported to associate with the cytoplasmic domain (IL-5Rα) of interleukin 5 receptor, which binds by its C-terminal amino acids to the PDZ domains of syntenin-1. As an additional binding partner, the transcription factor Sox4 was identified to bind to syntenin-1 outside the PDZ domains. The association of syntenin-1 with IL-5Rα was required for IL-5-mediated activation of Sox4. These studies demonstrate a mechanism of transcriptional activation by cytokinespecific receptors with syntenin-1 acting as an adaptor molecule. It was proposed that this signalling pathway could play a role in the regulation of early B cell development [40] . It is tempting to speculate that the syntenin-1/ESAT-6 interaction might contribute to the ability of M. tuberculosis to induce some form of immune-dysregulation to escape sterilizing immunity. It seems reasonable that binding of ESAT-6 to syntenin-1 could prevent the latter from its regulatory functions in infected cells.
New strategies to combat tuberculosis require a better understanding of the hostpathogen interaction by which M. tuberculosis evades both the innate and the adaptive immune response. ESAT-6 is believed to be one of the effector molecules involved in macrophage subversion [18] . Recent studies of Majlessi et al. [53] have shown that products encoded by the ESAT-6 secretion system of M. tuberculosis profoundly modify the interaction between mycobacteria and the host innate and adaptive immune system. There is no information so far about the cellular proteins mediating ESAT-6 effects in the mammalian host.
In conclusion, we have identified an interaction between ESAT-6, an exported M. tuberculosis protein and syntenin-1, an intracellular host protein. The knowledge of proteinprotein interactions of the virulence factor ESAT-6 is of importance to understanding the role of ESAT-6 during the infection process. The interaction of ESAT-6 and syntenin-1 in infected cells, and the influences on cellular processes, remains to be explored in detail.
